Slotman Ben J
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
J Radiosurg SBRT. 2011;1(1):63-69.
In this manuscript, developments in the techniques, clinical outcome, toxicity, and future perspectives of SBRT for medically inoperable and operable early stage NCSLC are discussed. SBRT is well tolerated and has limited and acceptable side effects. It has evolved as a standard of care for medically inoperable patients. These excellent results taken together with the morbidity and mortality associated with surgery, might also lead to changes in the treatment for operable patients.
在本手稿中，讨论了立体定向体部放疗（SBRT）在医学上不可手术和可手术的早期非小细胞肺癌（NCSLC）中的技术进展、临床结果、毒性及未来前景。SBRT耐受性良好，副作用有限且可接受。它已发展成为医学上不可手术患者的一种标准治疗方法。这些优异的结果，再加上与手术相关的发病率和死亡率，可能也会导致可手术患者治疗方式的改变。
